TDS（経皮デリバリーシステム）のグローバル市場 2021年：企業別、地域別、種類・用途別

• 英文タイトル：Global TDS(Transdermal Delivery Systems) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-203B16346 • 出版社/出版日：GlobalInfoResearch / 2021年12月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

TDS（経皮デリバリーシステム）市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。 GlobalInfoResearchの最新の調査によると、世界のTDS（経皮デリバリーシステム）の市場規模は2020年のxxx米ドルから2021年にはxxx米ドルと推定され、2020年から2021年の間にxxx％の変化があります。世界のTDS（経皮デリバリーシステム）の市場規模は次の5年間でxxx％のCAGRで成長すると予想されます。 TDS（経皮デリバリーシステム）市場は種類と用途によって区分されます。2016年～2026年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。 種類別セグメントは次をカバーします。 ・単層接着剤、多層接着剤、その他 用途別セグメントは次のように区分されます。 ・病院、クリニック、その他 世界のTDS（経皮デリバリーシステム）市場の主要な市場プレーヤーは以下のとおりです。 ・Adhex Pharma、Harro Hofliger、Tesa Labtec、Toyochem、Teva Pharmaceutical、Pfizer、IBSA Group、Teikoku Seiyaku、Endo International、Hisamitsu、Mylan、Sorrento Therapeutics 地域別セグメントは次の地域・国をカバーします。 ・北米（米国、カナダ、メキシコ） ・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア） ・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア） ・南アメリカ（ブラジル、アルゼンチン、コロンビア） ・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ） 本調査レポートの内容は計14章あります。 ・第1章では、TDS（経皮デリバリーシステム）製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。 ・第2章では、主要なTDS（経皮デリバリーシステム）メーカーの企業概要、2019年～2021年までのTDS（経皮デリバリーシステム）の価格、販売量、売上、市場シェアを掲載しています。 ・第3章では、主要なTDS（経皮デリバリーシステム）メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。 ・第4章では、2016年～2026年までの地域別TDS（経皮デリバリーシステム）の販売量、売上、成長性を示しています。 ・第5、6章では、2016年～2026年までのTDS（経皮デリバリーシステム）の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。 ・第7、8、9、10、11章では、2016年～2021年までの世界の主要国での販売量、売上、市場シェア、並びに2021年～2026年までの主要地域でのTDS（経皮デリバリーシステム）市場予測を収録しています。 ・第12、13、14章では、TDS（経皮デリバリーシステム）の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。 ***** 目次(一部) ***** ・市場概要 ・メーカー情報（企業概要、製品概要、販売量、価格、売上）：Adhex Pharma、Harro Hofliger、Tesa Labtec、Toyochem、Teva Pharmaceutical、Pfizer、IBSA Group、Teikoku Seiyaku、Endo International、Hisamitsu、Mylan、Sorrento Therapeutics ・メーカー別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：単層接着剤、多層接着剤、その他 ・用途別分析2016年-2026年：病院、クリニック、その他 ・TDS（経皮デリバリーシステム）の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・TDS（経皮デリバリーシステム）のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・TDS（経皮デリバリーシステム）のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・TDS（経皮デリバリーシステム）の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・TDS（経皮デリバリーシステム）の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The TDS(Transdermal Delivery Systems) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global TDS(Transdermal Delivery Systems) size is estimated to be xx million in 2021 from USD xx million in 2020, with a change of XX% between 2020 and 2021. The global TDS(Transdermal Delivery Systems) market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
TDS(Transdermal Delivery Systems) market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Single-layer Drug-in-Adhesive
Multi-layer Drug-in-Adhesive
Others

Market segment by Application can be divided into
Hospital
Clinic
Other

The key market players for global TDS(Transdermal Delivery Systems) market are listed below:
Adhex Pharma
Harro Hofliger
Tesa Labtec
Toyochem
Teva Pharmaceutical
Pfizer
IBSA Group
Teikoku Seiyaku
Endo International
Hisamitsu
Mylan
Sorrento Therapeutics

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

The content of the study subjects, includes a total of 14 chapters:
Chapter 1, to describe TDS(Transdermal Delivery Systems) product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of TDS(Transdermal Delivery Systems), with price, sales, revenue and global market share of TDS(Transdermal Delivery Systems) in 2018 and 2019.
Chapter 3, the TDS(Transdermal Delivery Systems) competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the TDS(Transdermal Delivery Systems) breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5 and 6, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2016 to 2021.and TDS(Transdermal Delivery Systems) market forecast, by regions, type and application, with sales and revenue, from 2021 to 2026.
Chapter 12, 13 and 14, to describe TDS(Transdermal Delivery Systems) sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 TDS(Transdermal Delivery Systems) Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global TDS(Transdermal Delivery Systems) Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Single-layer Drug-in-Adhesive
1.2.3 Multi-layer Drug-in-Adhesive
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global TDS(Transdermal Delivery Systems) Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global TDS(Transdermal Delivery Systems) Market Size & Forecast
1.4.1 Global TDS(Transdermal Delivery Systems) Sales in Value (2016-2026))
1.4.2 Global TDS(Transdermal Delivery Systems) Sales in Volume (2016-2026)
1.4.3 Global TDS(Transdermal Delivery Systems) Price by Type (2016-2026) & (USD/Unit)
1.5 Global TDS(Transdermal Delivery Systems) Production Capacity Analysis
1.5.1 Global TDS(Transdermal Delivery Systems) Total Production Capacity (2016-2026)
1.5.2 Global TDS(Transdermal Delivery Systems) Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 TDS(Transdermal Delivery Systems) Market Drivers
1.6.2 TDS(Transdermal Delivery Systems) Market Restraints
1.6.3 TDS(Transdermal Delivery Systems) Trends Analysis
2 Manufacturers Profiles
2.1 Adhex Pharma
2.1.1 Adhex Pharma Details
2.1.2 Adhex Pharma Major Business
2.1.3 Adhex Pharma TDS(Transdermal Delivery Systems) Product and Services
2.1.4 Adhex Pharma TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.2 Harro Hofliger
2.2.1 Harro Hofliger Details
2.2.2 Harro Hofliger Major Business
2.2.3 Harro Hofliger TDS(Transdermal Delivery Systems) Product and Services
2.2.4 Harro Hofliger TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.3 Tesa Labtec
2.3.1 Tesa Labtec Details
2.3.2 Tesa Labtec Major Business
2.3.3 Tesa Labtec TDS(Transdermal Delivery Systems) Product and Services
2.3.4 Tesa Labtec TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.4 Toyochem
2.4.1 Toyochem Details
2.4.2 Toyochem Major Business
2.4.3 Toyochem TDS(Transdermal Delivery Systems) Product and Services
2.4.4 Toyochem TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.5 Teva Pharmaceutical
2.5.1 Teva Pharmaceutical Details
2.5.2 Teva Pharmaceutical Major Business
2.5.3 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Product and Services
2.5.4 Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.6 Pfizer
2.6.1 Pfizer Details
2.6.2 Pfizer Major Business
2.6.3 Pfizer TDS(Transdermal Delivery Systems) Product and Services
2.6.4 Pfizer TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.7 IBSA Group
2.7.1 IBSA Group Details
2.7.2 IBSA Group Major Business
2.7.3 IBSA Group TDS(Transdermal Delivery Systems) Product and Services
2.7.4 IBSA Group TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.8 Teikoku Seiyaku
2.8.1 Teikoku Seiyaku Details
2.8.2 Teikoku Seiyaku Major Business
2.8.3 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Product and Services
2.8.4 Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.9 Endo International
2.9.1 Endo International Details
2.9.2 Endo International Major Business
2.9.3 Endo International TDS(Transdermal Delivery Systems) Product and Services
2.9.4 Endo International TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.10 Hisamitsu
2.10.1 Hisamitsu Details
2.10.2 Hisamitsu Major Business
2.10.3 Hisamitsu TDS(Transdermal Delivery Systems) Product and Services
2.10.4 Hisamitsu TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.11 Mylan
2.11.1 Mylan Details
2.11.2 Mylan Major Business
2.11.3 Mylan TDS(Transdermal Delivery Systems) Product and Services
2.11.4 Mylan TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
2.12 Sorrento Therapeutics
2.12.1 Sorrento Therapeutics Details
2.12.2 Sorrento Therapeutics Major Business
2.12.3 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Product and Services
2.12.4 Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales, Price, Revenue, Gross Margin and Market Share (2019-2021)
3 TDS(Transdermal Delivery Systems) Sales by Manufacturer
3.1 Global TDS(Transdermal Delivery Systems) Sales in Volume by Manufacturer (2019-2021e)
3.2 Global TDS(Transdermal Delivery Systems) Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in TDS(Transdermal Delivery Systems)
3.4 Market Concentration Rate
3.4.1 Top 3 TDS(Transdermal Delivery Systems) Manufacturer Market Share
3.4.2 Top 6 TDS(Transdermal Delivery Systems) Manufacturer Market Share
3.5 Global TDS(Transdermal Delivery Systems) Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and TDS(Transdermal Delivery Systems) Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global TDS(Transdermal Delivery Systems) Market Size by Region
4.1.1 Global TDS(Transdermal Delivery Systems) Sales in Volume by Region (2016-2026)
4.1.2 Global TDS(Transdermal Delivery Systems) Revenue by Region (2016-2026)
4.2 North America TDS(Transdermal Delivery Systems) Revenue (2016-2026)
4.3 Europe TDS(Transdermal Delivery Systems) Revenue (2016-2026)
4.4 Asia-Pacific TDS(Transdermal Delivery Systems) Revenue (2016-2026)
4.5 South America TDS(Transdermal Delivery Systems) Revenue (2016-2026)
4.6 Middle East and Africa TDS(Transdermal Delivery Systems) Revenue (2016-2026)
5 Market Segment by Type
5.1 Global TDS(Transdermal Delivery Systems) Sales in Volume by Type (2016-2026)
5.2 Global TDS(Transdermal Delivery Systems) Revenue by Type (2016-2026)
5.3 Global TDS(Transdermal Delivery Systems) Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global TDS(Transdermal Delivery Systems) Sales in Volume by Application (2016-2026)
6.2 Global TDS(Transdermal Delivery Systems) Revenue by Application (2016-2026)
6.3 Global TDS(Transdermal Delivery Systems) Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America TDS(Transdermal Delivery Systems) Sales by Type (2016-2026)
7.2 North America TDS(Transdermal Delivery Systems) Sales by Application (2016-2026)
7.3 North America TDS(Transdermal Delivery Systems) Market Size by Country
7.3.1 North America TDS(Transdermal Delivery Systems) Sales in Volume by Country (2016-2026)
7.3.2 North America TDS(Transdermal Delivery Systems) Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe TDS(Transdermal Delivery Systems) Sales by Type (2016-2026)
8.2 Europe TDS(Transdermal Delivery Systems) Sales by Application (2016-2026)
8.3 Europe TDS(Transdermal Delivery Systems) Market Size by Country
8.3.1 Europe TDS(Transdermal Delivery Systems) Sales in Volume by Country (2016-2026)
8.3.2 Europe TDS(Transdermal Delivery Systems) Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Type (2016-2026)
9.2 Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Application (2016-2026)
9.3 Asia-Pacific TDS(Transdermal Delivery Systems) Market Size by Region
9.3.1 Asia-Pacific TDS(Transdermal Delivery Systems) Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific TDS(Transdermal Delivery Systems) Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America TDS(Transdermal Delivery Systems) Sales by Type (2016-2026)
10.2 South America TDS(Transdermal Delivery Systems) Sales by Application (2016-2026)
10.3 South America TDS(Transdermal Delivery Systems) Market Size by Country
10.3.1 South America TDS(Transdermal Delivery Systems) Sales in Volume by Country (2016-2026)
10.3.2 South America TDS(Transdermal Delivery Systems) Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Type (2016-2026)
11.2 Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Application (2016-2026)
11.3 Middle East & Africa TDS(Transdermal Delivery Systems) Market Size by Country
11.3.1 Middle East & Africa TDS(Transdermal Delivery Systems) Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa TDS(Transdermal Delivery Systems) Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 TDS(Transdermal Delivery Systems) Typical Distributors
12.3 TDS(Transdermal Delivery Systems) Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global TDS(Transdermal Delivery Systems) Revenue by Type, (USD Million), 2021-2026
Table 2. Global TDS(Transdermal Delivery Systems) Revenue by Application, (USD Million), 2021-2026
Table 3. Adhex Pharma Basic Information, Manufacturing Base and Competitors
Table 4. Adhex Pharma Major Business
Table 5. Adhex Pharma TDS(Transdermal Delivery Systems) Product and Services
Table 6. Adhex Pharma TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Harro Hofliger Basic Information, Manufacturing Base and Competitors
Table 8. Harro Hofliger Major Business
Table 9. Harro Hofliger TDS(Transdermal Delivery Systems) Product and Services
Table 10. Harro Hofliger TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Tesa Labtec Basic Information, Manufacturing Base and Competitors
Table 12. Tesa Labtec Major Business
Table 13. Tesa Labtec TDS(Transdermal Delivery Systems) Product and Services
Table 14. Tesa Labtec TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Toyochem Basic Information, Manufacturing Base and Competitors
Table 16. Toyochem Major Business
Table 17. Toyochem TDS(Transdermal Delivery Systems) Product and Services
Table 18. Toyochem TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. Teva Pharmaceutical Major Business
Table 21. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Product and Services
Table 22. Teva Pharmaceutical TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Pfizer Basic Information, Manufacturing Base and Competitors
Table 24. Pfizer Major Business
Table 25. Pfizer TDS(Transdermal Delivery Systems) Product and Services
Table 26. Pfizer TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. IBSA Group Basic Information, Manufacturing Base and Competitors
Table 28. IBSA Group Major Business
Table 29. IBSA Group TDS(Transdermal Delivery Systems) Product and Services
Table 30. IBSA Group TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Teikoku Seiyaku Basic Information, Manufacturing Base and Competitors
Table 32. Teikoku Seiyaku Major Business
Table 33. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Product and Services
Table 34. Teikoku Seiyaku TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Endo International Basic Information, Manufacturing Base and Competitors
Table 36. Endo International Major Business
Table 37. Endo International TDS(Transdermal Delivery Systems) Product and Services
Table 38. Endo International TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Hisamitsu Basic Information, Manufacturing Base and Competitors
Table 40. Hisamitsu Major Business
Table 41. Hisamitsu TDS(Transdermal Delivery Systems) Product and Services
Table 42. Hisamitsu TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. Mylan Basic Information, Manufacturing Base and Competitors
Table 44. Mylan Major Business
Table 45. Mylan TDS(Transdermal Delivery Systems) Product and Services
Table 46. Mylan TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table 48. Sorrento Therapeutics Major Business
Table 49. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Product and Services
Table 50. Sorrento Therapeutics TDS(Transdermal Delivery Systems) Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Global TDS(Transdermal Delivery Systems) Sales by Manufacturer (2019-2021e) & (K Units)
Table 52. Global TDS(Transdermal Delivery Systems) Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 53. Market Position of Manufacturers in TDS(Transdermal Delivery Systems), (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 54. Global TDS(Transdermal Delivery Systems) Production Capacity by Company, (K Units): 2020 VS 2021
Table 55. Head Office and TDS(Transdermal Delivery Systems) Production Site of Key Manufacturer
Table 56. TDS(Transdermal Delivery Systems) New Entrant and Capacity Expansion Plans
Table 57. TDS(Transdermal Delivery Systems) Mergers & Acquisitions in the Past Five Years
Table 58. Global TDS(Transdermal Delivery Systems) Sales by Region (2016-2021e) & (K Units)
Table 59. Global TDS(Transdermal Delivery Systems) Sales by Region (2021-2026) & (K Units)
Table 60. Global TDS(Transdermal Delivery Systems) Revenue by Region (2016-2021e) & (USD Million)
Table 61. Global TDS(Transdermal Delivery Systems) Revenue by Region (2021-2026) & (USD Million)
Table 62. Global TDS(Transdermal Delivery Systems) Sales by Type (2016-2021e) & (K Units)
Table 63. Global TDS(Transdermal Delivery Systems) Sales by Type (2021-2026) & (K Units)
Table 64. Global TDS(Transdermal Delivery Systems) Revenue by Type (2016-2021e) & (USD Million)
Table 65. Global TDS(Transdermal Delivery Systems) Revenue by Type (2021-2026) & (USD Million)
Table 66. Global TDS(Transdermal Delivery Systems) Price by Type (2016-2021e) & (USD/Unit)
Table 67. Global TDS(Transdermal Delivery Systems) Price by Type (2021-2026) & (USD/Unit)
Table 68. Global TDS(Transdermal Delivery Systems) Sales by Application (2016-2021e) & (K Units)
Table 69. Global TDS(Transdermal Delivery Systems) Sales by Application (2021-2026) & (K Units)
Table 70. Global TDS(Transdermal Delivery Systems) Revenue by Application (2016-2021e) & (USD Million)
Table 71. Global TDS(Transdermal Delivery Systems) Revenue by Application (2021-2026) & (USD Million)
Table 72. Global TDS(Transdermal Delivery Systems) Price by Application (2016-2021e) & (USD/Unit)
Table 73. Global TDS(Transdermal Delivery Systems) Price by Application (2021-2026) & (USD/Unit)
Table 74. North America TDS(Transdermal Delivery Systems) Sales by Country (2016-2021e) & (K Units)
Table 75. North America TDS(Transdermal Delivery Systems) Sales by Country (2021-2026) & (K Units)
Table 76. North America TDS(Transdermal Delivery Systems) Revenue by Country (2016-2021e) & (USD Million)
Table 77. North America TDS(Transdermal Delivery Systems) Revenue by Country (2021-2026) & (USD Million)
Table 78. North America TDS(Transdermal Delivery Systems) Sales by Type (2016-2021e) & (K Units)
Table 79. North America TDS(Transdermal Delivery Systems) Sales by Type (2021-2026) & (K Units)
Table 80. North America TDS(Transdermal Delivery Systems) Sales by Application (2016-2021e) & (K Units)
Table 81. North America TDS(Transdermal Delivery Systems) Sales by Application (2021-2026) & (K Units)
Table 82. Europe TDS(Transdermal Delivery Systems) Sales by Country (2016-2021e) & (K Units)
Table 83. Europe TDS(Transdermal Delivery Systems) Sales by Country (2021-2026) & (K Units)
Table 84. Europe TDS(Transdermal Delivery Systems) Revenue by Country (2016-2021e) & (USD Million)
Table 85. Europe TDS(Transdermal Delivery Systems) Revenue by Country (2021-2026) & (USD Million)
Table 86. Europe TDS(Transdermal Delivery Systems) Sales by Type (2016-2021e) & (K Units)
Table 87. Europe TDS(Transdermal Delivery Systems) Sales by Type (2021-2026) & (K Units)
Table 88. Europe TDS(Transdermal Delivery Systems) Sales by Application (2016-2021e) & (K Units)
Table 89. Europe TDS(Transdermal Delivery Systems) Sales by Application (2021-2026) & (K Units)
Table 90. Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Region (2016-2021e) & (K Units)
Table 91. Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Region (2021-2026) & (K Units)
Table 92. Asia-Pacific TDS(Transdermal Delivery Systems) Revenue by Region (2016-2021e) & (USD Million)
Table 93. Asia-Pacific TDS(Transdermal Delivery Systems) Revenue by Region (2021-2026) & (USD Million)
Table 94. Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Type (2016-2021e) & (K Units)
Table 95. Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Type (2021-2026) & (K Units)
Table 96. Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Application (2016-2021e) & (K Units)
Table 97. Asia-Pacific TDS(Transdermal Delivery Systems) Sales by Application (2021-2026) & (K Units)
Table 98. South America TDS(Transdermal Delivery Systems) Sales by Country (2016-2021e) & (K Units)
Table 99. South America TDS(Transdermal Delivery Systems) Sales by Country (2021-2026) & (K Units)
Table 100. South America TDS(Transdermal Delivery Systems) Revenue by Country (2016-2021e) & (USD Million)
Table 101. South America TDS(Transdermal Delivery Systems) Revenue by Country (2021-2026) & (USD Million)
Table 102. South America TDS(Transdermal Delivery Systems) Sales by Type (2016-2021e) & (K Units)
Table 103. South America TDS(Transdermal Delivery Systems) Sales by Type (2021-2026) & (K Units)
Table 104. South America TDS(Transdermal Delivery Systems) Sales by Application (2016-2021e) & (K Units)
Table 105. South America TDS(Transdermal Delivery Systems) Sales by Application (2021-2026) & (K Units)
Table 106. Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Country (2016-2021e) & (K Units)
Table 107. Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Country (2021-2026) & (K Units)
Table 108. Middle East & Africa TDS(Transdermal Delivery Systems) Revenue by Country (2016-2021e) & (USD Million)
Table 109. Middle East & Africa TDS(Transdermal Delivery Systems) Revenue by Country (2021-2026) & (USD Million)
Table 110. Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Type (2016-2021e) & (K Units)
Table 111. Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Type (2021-2026) & (K Units)
Table 112. Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Application (2016-2021e) & (K Units)
Table 113. Middle East & Africa TDS(Transdermal Delivery Systems) Sales by Application (2021-2026) & (K Units)
Table 114. Direct Channel Pros & Cons
Table 115. Indirect Channel Pros & Cons
Table 116. TDS(Transdermal Delivery Systems) Typical Distributors
Table 117. TDS(Transdermal Delivery Systems) Typical Customers
List of Figures
Figure 1. TDS(Transdermal Delivery Systems) Picture
Figure 2. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type in 2020
Figure 3. Single-layer Drug-in-Adhesive
Figure 4. Multi-layer Drug-in-Adhesive
Figure 5. Others
Figure 6. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application in 2020
Figure 7. Hospital
Figure 8. Clinic
Figure 9. Other
Figure 10. Global TDS(Transdermal Delivery Systems) Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 11. Global TDS(Transdermal Delivery Systems) Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. Global TDS(Transdermal Delivery Systems) Sales (2016-2026) & (K Units)
Figure 13. Global TDS(Transdermal Delivery Systems) Price by Type (2016-2026) & (USD/Unit)
Figure 14. Global TDS(Transdermal Delivery Systems) Production Capacity (2016-2026) & (K Units)
Figure 15. Global TDS(Transdermal Delivery Systems) Production Capacity by Geographic Region: 2020 VS 2021
Figure 16. TDS(Transdermal Delivery Systems) Market Drivers
Figure 17. TDS(Transdermal Delivery Systems) Market Restraints
Figure 18. TDS(Transdermal Delivery Systems) Market Trends
Figure 19. Global TDS(Transdermal Delivery Systems) Sales Market Share by Manufacturer in 2020
Figure 20. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Manufacturer in 2020
Figure 21. TDS(Transdermal Delivery Systems) Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 22. Top 3 TDS(Transdermal Delivery Systems) Manufacturer (Revenue) Market Share in 2020
Figure 23. Top 6 TDS(Transdermal Delivery Systems) Manufacturer (Revenue) Market Share in 2020
Figure 24. Global TDS(Transdermal Delivery Systems) Sales Market Share by Region (2016-2026)
Figure 25. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2016-2026)
Figure 26. North America TDS(Transdermal Delivery Systems) Revenue (2016-2026) & (USD Million)
Figure 27. Europe TDS(Transdermal Delivery Systems) Revenue (2016-2026) & (USD Million)
Figure 28. Asia-Pacific TDS(Transdermal Delivery Systems) Revenue (2016-2026) & (USD Million)
Figure 29. South America TDS(Transdermal Delivery Systems) Revenue (2016-2026) & (USD Million)
Figure 30. Middle East & Africa TDS(Transdermal Delivery Systems) Revenue (2016-2026) & (USD Million)
Figure 31. Global TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2026)
Figure 32. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Type (2016-2026)
Figure 33. Global TDS(Transdermal Delivery Systems) Price by Type (2016-2026) & (USD/Unit)
Figure 34. Global TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2026)
Figure 35. Global TDS(Transdermal Delivery Systems) Revenue Market Share by Application (2016-2026)
Figure 36. Global TDS(Transdermal Delivery Systems) Price by Application (2016-2026) & (USD/Unit)
Figure 37. North America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2026)
Figure 38. North America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2026)
Figure 39. North America TDS(Transdermal Delivery Systems) Sales Market Share by Country (2016-2026)
Figure 40. North America TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2016-2026)
Figure 41. United States TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 42. Canada TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 43. Mexico TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 44. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2026)
Figure 45. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2026)
Figure 46. Europe TDS(Transdermal Delivery Systems) Sales Market Share by Country (2016-2026)
Figure 47. Europe TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2016-2026)
Figure 48. Germany TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 49. France TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 50. United Kingdom TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 51. Russia TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. Italy TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. Asia-Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Region (2016-2026)
Figure 54. Asia-Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2026)
Figure 55. Asia-Pacific TDS(Transdermal Delivery Systems) Sales Market Share by Region (2016-2026)
Figure 56. Asia-Pacific TDS(Transdermal Delivery Systems) Revenue Market Share by Region (2016-2026)
Figure 57. China TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 58. Japan TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 59. Korea TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. India TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. Southeast Asia TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. Australia TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. South America TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2026)
Figure 64. South America TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2026)
Figure 65. South America TDS(Transdermal Delivery Systems) Sales Market Share by Country (2016-2026)
Figure 66. South America TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2016-2026)
Figure 67. Brazil TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 68. Argentina TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Middle East & Africa TDS(Transdermal Delivery Systems) Sales Market Share by Type (2016-2026)
Figure 70. Middle East & Africa TDS(Transdermal Delivery Systems) Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa TDS(Transdermal Delivery Systems) Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa TDS(Transdermal Delivery Systems) Revenue Market Share by Country (2016-2026)
Figure 73. Turkey TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Egypt TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. Saudi Arabia TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. South Africa TDS(Transdermal Delivery Systems) Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 77. Sales Channel: Direct Channel vs Indirect Channel
Figure 78. Methodology
Figure 79. Research Process and Data Source

---